http://www.unboundmedicine.com/medline/ebm/research/glimepirideUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19925617/full_citation/Adding_liraglutide_to_oral_antidiabetic_drug_therapy:_onset_of_treatment_effects_over_time_Gallwitz B, Vaag A, Falahati A, et al. 
Adding liraglutide to oral antidiabetic drug therapy: onset of treatment effects over time. [JOURNAL ARTICLE]
Int J Clin Pract 2009 Nov 19.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19904502/full_citation/Complementary_and_Comparative_Study_on_Hypoglycemic_and_Antihyperglycemic_Activity_of_Various_Extracts_of_Eugenia_jambolana_Seed_Momordica_charantia_Fruits_Gymnema_sylvestre_and_Trigonella_foenum_graecum_Seeds_in_Rats_Yadav M, Lavania A, Tomar R, et al. 
Complementary and Comparative Study on Hypoglycemic and Antihyperglycemic Activity of Various Extracts of Eugenia jambolana Seed, Momordica charantia Fruits, Gymnema sylvestre, and Trigonella foenum graecum Seeds in Rats. [JOURNAL ARTICLE]
Appl Biochem Biotechnol 2009 Nov 11.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19891554/full_citation/Presence_of_CYP2C9_3_allele_increases_risk_for_hypoglycemia_in_Type_2_diabetic_patients_treated_with_sulfonylureas_Ragia G, Petridis I, Tavridou A, et al. 
Presence of CYP2C9*3 allele increases risk for hypoglycemia in Type 2 diabetic patients treated with sulfonylureas. [Journal Article]
Pharmacogenomics 2009 Nov; 10(11):1781-7.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19878259/full_citation/The_safety_and_efficacy_of_liraglutide_with_or_without_oral_antidiabetic_drug_therapy_in_type_2_diabetes:_an_overview_of_the_LEAD_1_5_studies_Blonde L, Russell-Jones D 
The safety and efficacy of liraglutide with or without oral antidiabetic drug therapy in type 2 diabetes: an overview of the LEAD 1-5 studies. [JOURNAL ARTICLE]
Diabetes Obes Metab 2009 Dec; 11(s3):26-34.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19873688/full_citation/A_simulation_of_the_comparative_long_term_effectiveness_of_liraglutide_and_glimepiride_monotherapies_in_patients_with_type_2_diabetes_mellitus_Sullivan SD, Alfonso-Cristancho R, Conner C, et al. 
A simulation of the comparative long-term effectiveness of liraglutide and glimepiride monotherapies in patients with type 2 diabetes mellitus. [Journal Article]
Pharmacotherapy 2009 Nov; 29(11):1280-8.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19821654/full_citation/Once_daily_initiation_with_biphasic_insulin_aspart_30_versus_insulin_glargine_in_patients_with_type_2_diabetes_inadequately_controlled_with_oral_drugs:_an_open_label_multinational_RCT_Strojek K, Bebakar WM, Khutsoane DT, et al. 
Once-daily initiation with biphasic insulin aspart 30 versus insulin glargine in patients with type 2 diabetes inadequately controlled with oral drugs: an open-label, multinational RCT. [JOURNAL ARTICLE]
Curr Med Res Opin 2009 Oct 12.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19800638/full_citation/Glimepiride_induces_proliferation_and_differentiation_of_rat_osteoblasts_via_the_PI3_kinase/Akt_pathway_Ma P, Gu B, Ma J, et al. 
Glimepiride induces proliferation and differentiation of rat osteoblasts via the PI3-kinase/Akt pathway. [JOURNAL ARTICLE]
Metabolism 2009 Oct 1.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19799532/full_citation/Influence_of_genetic_polymorphisms_on_the_pharmacokinetics_and_pharmaco_dynamics_of_sulfonylurea_drugs_Xu H, Murray M, McLachlan AJ 
Influence of genetic polymorphisms on the pharmacokinetics and pharmaco-dynamics of sulfonylurea drugs. [Journal Article]
Curr Drug Metab 2009 Jul; 10(6):643-58.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19796836/full_citation/Glibenclamide_related_excess_in_total_and_cardiovascular_mortality_risks:_Data_from_large_Ukrainian_observational_cohort_study_Khalangot M, Tronko M, Kravchenko V, et al. 
Glibenclamide-related excess in total and cardiovascular mortality risks: Data from large Ukrainian observational cohort study. [JOURNAL ARTICLE]
Diabetes Res Clin Pract 2009 Sep 29.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19765654/full_citation/Triple_verses_Glimepiride_plus_Metformin_therapy_on_Cardiovascular_Risk_Biomarkers_and_Diabetic_Cardiomyopathy_in_Insulin_Resistance_Type_2_Diabetes_Mellitus_Rats_Sharma AK, Srinivasan BP 
Triple verses Glimepiride plus Metformin therapy on Cardiovascular Risk Biomarkers and Diabetic-Cardiomyopathy in Insulin Resistance Type 2 Diabetes Mellitus Rats. [JOURNAL ARTICLE]
Eur J Pharm Sci 2009 Sep 15.
Abstract | Full Citation